Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
F-box and WD repeat domain containing protein 10B (FBXW10B) is a member of the F-box protein family, characterized by the presence of an F-box domain and several WD repeat domains. F-box proteins are generally components of the SCF (SKP1-CUL1-F-box protein) E3 ubiquitin ligase complex, which mediates ubiquitination and proteasomal degradation of protein substrates. The specific biological function of FBXW10B remains uncharacterized. The gene is annotated as a putative pseudogene, and direct evidence for its involvement as a functional protein or as a validated drug target is lacking. Genomic location of FBXW10B is associated with the CMT1A repeat region on chromosome 17, which is duplicated in Charcot-Marie-Tooth disease type 1A. There are currently no known drugs, drug mechanisms, or established biomarker roles for this gene. Its inclusion in biomarker panels or therapeutic contexts appears unsupported; thus, it is not considered a bona fide therapeutic target[1][2][4][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on F-box and WD repeat domain containing protein 10B (FBXW10B).